Unregistered Sales of Equity Securities

Conexeu Sciences Inc. (CNXU) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Conexeu Sciences Inc. on June 9, 2026, covering events occurring on June 4, 2026, and June 8, 2026. The Company is an emerging growth company incorporated in Nevada with its principal executive offices in Reno, Nevada. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "CNXU".

Key Financial Metrics and Capital Events

The filing details two distinct warrant exercise events resulting in capital raises and share issuance:

  • Standard Warrant Exercise (June 4, 2026): Issued 416,667 shares of common stock for gross proceeds of approximately $166,667. Proceeds are designated for general working capital.
  • Performance Warrant Exercise (June 8, 2026): Issued 100,000 shares of common stock at $0.001 per share for gross proceeds of $100.
  • Share Count: Following the June 4 exercise, 26,658,330 shares were outstanding. Following the June 8 exercise, the total outstanding shares increased to 26,758,330.

The filing does not provide data on revenue, net profit, operating cash flow, margins, debt levels, or liquidity ratios.

Material Changes and Incentive Programs

The Company implemented a Warrant Exercise Incentive Program effective October 31, 2025, to encourage early exercise of up to 5,733,226 outstanding warrants ("Program Warrants").

  • Incentive Terms: Holders exercising Program Warrants by June 30, 2026, receive one additional "Incentive Warrant" for each Program Warrant exercised.
  • Incentive Warrant Details: Each Incentive Warrant allows the purchase of one additional share at $2.30 per share, exercisable for 36 months from issuance.
  • Execution: On June 4, 2026, 416,667 Incentive Warrants were issued to a single holder. Following this transaction, 410,338 Program Warrants remain outstanding.

Guidance, Risks, and Regulatory Status

The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard regulatory disclosures.

  • Regulatory Exemptions: The June 4 issuance relied on Rule 903(b) of Regulation S (non-U.S. person exemption). The June 8 issuance relied on Section 4(a)(2) and Rule 506(b) of Regulation D.
  • Registration Status: The 416,667 shares issued on June 4 are registered for resale under a Form S-1 declared effective on May 11, 2026. The shares underlying the Incentive Warrants are not registered and will only be issuable in exempt transactions.

Investor Verification Checklist

  • Verify the current market price of CNXU relative to the $2.30 exercise price of the newly issued Incentive Warrants.
  • Confirm the total number of outstanding warrants (410,338 Program Warrants plus 416,667 Incentive Warrants) and their respective expiration dates.
  • Review the Company's cash position to assess the impact of the $166,767 in gross proceeds on working capital needs.
  • Check for any subsequent filings regarding the exercise of the remaining Program Warrants before the June 30, 2026 deadline.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.